Company Filing History:
2 out of 1,745 
1 out of 1 
1 out of 3 Years Active: 2015-2016
Title: François Le Naour: Innovator in Cancer Management
Introduction
François Le Naour is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer management through his innovative research and patents. With a total of 2 patents, his work focuses on methods that target specific cancer-related proteins.
Latest Patents
Le Naour's latest patents revolve around the development of Co-029 inhibitors. These inhibitors are designed to inhibit the migration of cancer cells that express Co-029. His disclosures include methods for treating cancer and preventing metastasis, as well as pharmaceutical compositions that incorporate these inhibitors. Additionally, he has developed methods for predicting patient responses to treatment, diagnosing cancer, and forecasting survival rates in cancer patients.
Career Highlights
Throughout his career, François Le Naour has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Paris XI Paris Sud. His research has been pivotal in advancing cancer treatment methodologies.
Collaborations
Le Naour has collaborated with notable colleagues, including Eric Rubinstein and Céline Greco. These partnerships have further enriched his research and contributed to the development of innovative cancer management strategies.
Conclusion
François Le Naour's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents and research continue to pave the way for advancements in cancer treatment and patient care.